Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,851 | 369 | 94.6% |
| Travel and Lodging | $503.55 | 4 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,094 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $939.47 | 63 | $0 (2024) |
| Boston Scientific Corporation | $522.69 | 11 | $0 (2024) |
| Intuitive Surgical, Inc. | $503.55 | 4 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $465.98 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $448.59 | 31 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $398.68 | 13 | $0 (2024) |
| PFIZER INC. | $362.30 | 21 | $0 (2023) |
| PROCEPT BioRobotics Corporation | $325.28 | 5 | $0 (2024) |
| Rochester Medical Corporation | $266.71 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,826 | 72 | Janssen Biotech, Inc. ($295.92) |
| 2023 | $1,904 | 69 | Dendreon Pharmaceuticals LLC ($314.92) |
| 2022 | $1,469 | 62 | Intuitive Surgical, Inc. ($503.55) |
| 2021 | $1,275 | 63 | Clarus Therapeutics Inc. ($214.36) |
| 2020 | $543.48 | 20 | Olympus America Inc. ($125.35) |
| 2019 | $1,030 | 38 | Dendreon Pharmaceuticals LLC ($467.89) |
| 2018 | $902.85 | 25 | Rochester Medical Corporation ($221.78) |
| 2017 | $404.14 | 24 | Astellas Pharma US Inc ($120.60) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $88.64 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $54.17 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $36.82 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: UROLOGY | ||||||
| 08/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: UROLOGY | ||||||
| 08/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,854 | 2,877 | $221,505 | $104,926 |
| 2022 | 21 | 1,918 | 2,858 | $206,767 | $107,485 |
| 2021 | 30 | 2,261 | 4,832 | $291,223 | $147,443 |
| 2020 | 32 | 2,632 | 6,298 | $357,969 | $154,447 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 396 | $60,192 | $32,175 | 53.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 87 | 126 | $25,830 | $14,686 | 56.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 48 | 323 | $22,610 | $14,383 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 214 | $22,042 | $12,528 | 56.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 45 | 49 | $21,070 | $7,750 | 36.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 186 | 255 | $9,690 | $4,595 | 47.4% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 20 | 20 | $10,124 | $3,433 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $5,598 | $2,715 | 48.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 407 | 670 | $9,380 | $2,582 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $5,300 | $2,460 | 46.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 233 | 338 | $14,534 | $2,234 | 15.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 205 | 274 | $1,667 | $1,458 | 87.5% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 14 | 15 | $4,360 | $1,123 | 25.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 27 | 27 | $5,541 | $1,092 | 19.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 28 | 42 | $1,596 | $1,062 | 66.6% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 12 | 13 | $1,365 | $421.46 | 30.9% |
| 82565 | Blood creatinine level | Office | 2023 | 21 | 21 | $241.50 | $105.42 | 43.7% |
| 85014 | Red blood cell concentration measurement | Office | 2023 | 17 | 26 | $182.00 | $60.32 | 33.1% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 17 | 26 | $182.00 | $60.32 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 257 | 322 | $48,944 | $26,269 | 53.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 126 | 167 | $34,235 | $20,421 | 59.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 58 | 361 | $22,535 | $15,176 | 67.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 212 | $21,836 | $12,734 | 58.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 28 | 31 | $13,330 | $5,464 | 41.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 198 | 263 | $9,994 | $4,778 | 47.8% |
About Dr. Guy Oswalt, M.D
Dr. Guy Oswalt, M.D is a Urology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376646505.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Oswalt, M.D has received a total of $9,355 in payments from pharmaceutical and medical device companies, with $1,826 received in 2024. These payments were reported across 373 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($8,851).
As a Medicare-enrolled provider, Oswalt has provided services to 8,665 Medicare beneficiaries, totaling 16,865 services with total Medicare billing of $514,300. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Mobile, AL
- Active Since 09/06/2006
- Last Updated 01/25/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1376646505
Products in Payments
- PROVENGE (Drug) $1,107
- ERLEADA (Drug) $937.85
- Da Vinci Surgical System (Device) $503.55
- GEMTESA (Drug) $443.11
- XTANDI (Drug) $437.89
- PROLARIS (Device) $369.92
- AQUABEAM SYSTEM (Device) $284.73
- ORGOVYX (Drug) $280.70
- Axumin (Drug) $223.70
- MAGIC3 (Device) $221.78
- XIAFLEX (Biological) $221.63
- CAMCEVI (Drug) $221.39
- JATENZO (Drug) $214.36
- MYRBETRIQ (Drug) $209.04
- REZUM (Device) $207.72
- INTERSTIM (Device) $202.25
- Nubeqa (Drug) $173.14
- Erleada (Drug) $164.32
- ELIGARD (Drug) $162.13
- YONSA (Drug) $152.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Mobile
Zachary Reardon, Md, MD
Urology — Payments: $19,052
Ted Klein, M.d, M.D
Urology — Payments: $15,500
Dr. William Blaylock, Md, MD
Urology — Payments: $12,651
Dimple Kumar Chanamolu
Urology — Payments: $11,022
Dr. Thomas Coleman, Md, MD
Urology — Payments: $9,722
Paul Scott, M.d, M.D
Urology — Payments: $6,900